Introduction

Tamoxifen (TAM) has been used to treat breast cancer,1 with the potential for application as a cancer-preventing agent.2 Although the antiestrogenic properties of TAM appear to be responsible for the anticancer activities of TAM in breast cancer,3 the exact mechanisms of the actions of TAM are not yet clearly understood.

Apoptosis is a highly organized cell death process characterized by early and prominent condensation of nuclear chromatin, loss of plasma membrane phospholipid asymmetry, activation of proteases and endonucleases, enzymatic cleavage of the DNA into oligonucleosomal fragments, and segmentation of the cells into membrane-bound apoptotic bodies.4 TAM has been shown to induce apoptotic cell death in many types of tumor cells regardless of existence of estrogen receptor (ER).5,6,7,8 Although the signal transduction mechanisms by which TAM induces apoptosis in ER-negative tumor cells are essentially unknown, it is found to be associated with activation of the transcription factor NF-κB,7 or increased c-myc expression.8 Recently, we have also reported that TAM induces apoptosis through the activation of intracellular Ca2+ signal in ER-negative HepG2 human hepatoblastoma cells.9

Accumulating evidence implies that intracellular Ca2+ is commonly involved in the mechanism of apoptosis.10 One of the targets for elevated intracellular Ca2+ is the activation of the Ca2+-dependent protein kinases and phosphatases11 which has been seen during apoptosis.12 Direct activation of the Ca2+-dependent proteinase may represent another target for intracellular Ca2+ action in apoptosis.13 Ca2+/Mg2+-dependent endonuclease whose activation results in DNA fragmentation, the most characteristic biochemical feature of apoptosis,14 and Ca2+-dependent transglutaminase which is highly activated in apoptotic cells,15 also appear to be a target for Ca2+ action.16,17 The in vitro antitumor actions of TAM have been explained by its ability to perturb intracellular Ca2+ homeostasis.9,18 In HepG2 cells we have found that TAM induced a sustained Ca2+ influx through activation of non-specific cation channels leading to apoptotic cell death.9

There are numerous reports showing that oxidants kill cells by inducing apoptosis.19,20,21 In addition, oxidative stress is proposed as a common mechanism by which various agents induce apoptosis.22 Recently, reactive oxygen species (ROS) have also been demonstrated to play an essential role in apoptosis induced by TAM in ER-negative human cancer cells.7,23

Intracellular Ca2+ appears to be essential for generation of ROS in many cell types, including mitogen-activated human lymphocytes24 and growth factor-stimulated human keratinocytes.25 Extracellular Ca2+ influx is necessary for ROS generation during respiratory burst in human neutrophils.26 ROS production stimulated by excitotoxin is dependent on intracellular Ca2+ in rat cerebellar granule cells.27

Based on these previous findings, we hypothesized that TAM induces apoptosis through ROS generation mediated by elevated intracellular Ca2+. To verify this hypothesis, in this study we investigated (i) the role of ROS in the TAM-induced apoptosis in ER-negative HepG2 human hepatoblastoma cells, (ii) the cause-and-effect relationship between intracellular Ca2+ and ROS acting as a mediator of apoptosis, and (iii) the potential sites of ROS generation induced by TAM in the HepG2 cells.

Results

Induction of apoptotic cell death by TAM

We have previously reported that TAM induced apoptotic cell death in time- and concentration-dependent manners in the HepG2 cells.9 In this study we confirmed the apoptotic activity of TAM in the cells. TAM induced DNA fragmentation in a concentration-dependent manner studied by agarose gel electrophoresis as depicted in Figure 1A. This effect of TAM was prominent at the concentration of 30 μM. TAM also induced loss of phospholipid asymmetry, resulting in appearance of phosphatidylserine on the outer layer of the plasma membrane detected by annexin-V binding, as depicted in Figure 1B. Furthermore, TAM induced apoptosis in a time-related manner tested by flow cytometry by determining hypodiploid DNA content stained with PI28 as shown in Figure 1C. Taken together, these results indicate that TAM induced apoptotic cell death in the HepG2 cells.

Figure 1
figure 1

TAM induces apoptotic cell death in HepG2 human hepatoblastoma cells. In the experiments of (A) cells were treated for 48 h with or without each concentration of TAM. DNA was isolated from the cells and analyzed by 1.8% agarose gel electrophoresis. Lane M represents DNA marker. In the experiments of (B) cells were treated for 48 h with or without TAM (30 μM). Cells were stained with Annexin-V-FLUOS and analyzed by flow cytometry. In the experiments of (C) the cells were incubated with TAM (30 μM) for each designated time. The number of apoptotic cells was measured by flow cytometry as described in text. The region to the left of the G0/G1 peak, designated A0, was defined as cells undergoing apoptosis-associated DNA degradation.28 In bar graphs the data represent the mean values of four replications with bars indicating S.E.M. *P<0.05 compared to control

Role of ROS in the TAM-induced apoptosis

To determine the role of ROS in the TAM-induced apoptosis of HepG2 cells, we first examined whether TAM generates ROS assessed by 2′,7′-dichlorofluorescin diacetate (DCFH) fluorescence.29 As shown in Figure 2A, TAM (30 μM) induced a slow and sustained increase in intracellular ROS level, and this increase continued for at least 1 h, depicted in Figure 2B. The TAM-generated ROS was completely inhibited by an antioxidant, N-acetylcysteine (NAC) (50 mM) as illustrated in Figure 2B. To determine the role of ROS in the TAM-induced apoptosis, we investigated whether NAC could suppress the apoptosis induced by TAM. As shown in Figure 2C, NAC (50 mM) significantly lowered hypodiploid DNA content induced by TAM, indicating that ROS may be involved in the mechanism of the TAM-induced apoptosis in the HepG2 cells.

Figure 2
figure 2

Effects of NAC, an antioxidant on the ROS generation (A and B) and apoptosis (C) induced by TAM in HepG2 human hepatoblastoma cells. The data (A) show changes in ROS levels as a function of time, which was measured by DCF fluorescence method.29 The arrow shows the time point for addition of TAM (30 μM). NAC (50 mM) was added 10 min before TAM treatment. In the data (B) results are expressed as fold increase compared to the initial DCF fluorescence intensity. Data points represent the mean values for four replications with bars indicating S.E.M. *P<0.05 compared to control condition in which the cells were incubated with TAM-free medium. #P<0.05 compared to TAM alone. In the experiments of (C) the cells were incubated with TAM (30 μM) for 48 h. NAC (50 mM) was added 30 min before TAM treatment. The number of apoptotic cells was measured by flow cytometry. In bar graphs the data represent the mean values of four replications with bars indicating S.E.M. *P<0.05 compared to control. #P<0.05 compared to TAM alone

Role of intracellular Ca2+ on the ROS generation and apoptosis induced by TAM

Next, we investigated the possible interrelationship between intracellular Ca2+ and ROS in the apoptosis-inducing activity of TAM. Time-dependent changes in the levels of intracellular Ca2+ and ROS induced by TAM (30 μM) was compared with each other. Intracellular Ca2+ increase preceded the ROS generation as shown in Figure 3A. In addition, the TAM-induced ROS production was completely prevented by treatment with ethylene glycol-bis-(aminoethyl ether)N,N,N,N-tetraacetic acid (EGTA) (1 mM) and bis-(o-aminophenoxy)-ethane-N,N,N,N-tetraacetic acid/acetoxymethyl ester (BAPTA/AM) (1 μM), an extracellular and intracellular Ca2+ chelator, respectively, as illustrated in Figure 3B. These results imply that intracellular Ca2+ may act as an early signal for the production of ROS by TAM.

Figure 3
figure 3

Role of intracellular Ca2+ in the TAM-induced ROS generation in HepG2 human hepatoblastoma cells. In the data (A) the TAM (30 μM)-induced changes in intracellular ROS and Ca2+ levels are expressed as fold increase compared to the initial DCF fluorescence intensity and per cent of control condition in which the cells were incubated with TAM-free medium, respectively. In the data (B) the changes in intracellular ROS levels are expressed as fold increase compared to the initial DCF fluorescence intensity. EGTA (1 mM) and BAPTA/AM (1 μM) were added 10 min before TAM (30 μM) treatment. Data points represent the mean values of four replications with bars indicating S.E.M. *P<0.05 compared to control condition in which the cells were incubated with TAM-free medium. #P<0.05 compared to TAM alone

Role of NAD(P)H oxidase in the TAM-induced ROS generation and apoptosis

To clarify the sites of the TAM-induced ROS production, we investigated the effects of various drugs that inhibit the mitochondrial respiratory chain enzymes or non-mitochondrial ROS-generating enzymes, on the TAM-induced ROS generation and apoptosis. The results were summarized in Table 1. The effects of TAM (30 μM) on the ROS level and apoptosis were not significantly altered either by inhibition of mitochondrial electron transport with inhibitors of Complex I, succinate dehydrogenase or Complex III (10 μM rotenone, 5 mM malonate, rotenone+malonate, and 5 μM antimycin A, respectively) or by the mitochondrial uncoupler, carbonylcyanide-p-(trifluoromethoxy)phenylhydrazone (FCCP) (0.1 μM). These mitochondrial enzyme inhibitors did not have a significant influence on the basal level of ROS and apoptosis, except that antimycin A and FCCP significantly increased only the basal level of ROS. These results indicate that mitochondria may not be the site of ROS production induced by TAM.

Table 1 Effects of inhibitors of mitochondrial respiratory chain enzymes and non-mitochondrial ROS-generating enzymes on the TAM-induced ROS generation and apoptosis in HepG2 human hepatoblastoma cells

Thus, we examined whether non-mitochondrial ROS-generating enzymes contribute to the TAM-induced ROS production. The effects on the ROS and apoptosis of inhibitors of enzymes which can potentially generate ROS, cyclooxygenase, cytochrome P-450, nitric oxide synthase, xanthine oxidase and ribonucleotide reductase (100 μM indomethacin, 500 μM metyrapone, 100 μM NG-monomethyl-L-arginine (NMMA), 100 μM allopurinol and 1.5 mM hydroxyurea, respectively) were tested. The results showed that all drugs tested did not significantly influence the TAM-induced ROS increase and apoptosis, implying that these enzymes may not be actively involved in the TAM effects.

In contrast, inhibitors of membrane-bound NAD(P)H oxidase, 5 μM diphenylene iodonium (DPI),30 10 μM phenylarsine oxide (PAO)31 and 100 μM D-(+)-neopterine (NEO),32 significantly suppressed both the ROS generation and apoptosis induced by TAM as shown in Figure 4A,B, respectively. As a matter of fact, the activity of NAD(P)H oxidase similar to that found in neutrophils, has been detected in the HepG2 cells.33 Thus, these results strongly suggest that non-phagocytic NAD(P)H oxidase may act as a major site of ROS generation induced by TAM in the HepG2 cells.

Figure 4
figure 4

Effects of inhibitors of NAD(P)H oxidase on the TAM-induced ROS generation and apoptosis in HepG2 human hepatoblastoma cells. Data presentation is the same as Figure 1. In these experiments DPI (5 μM). PAO (10 μM) and NEO (100 μM) were used. These drugs were given 10 min and 30 min before TAM application in the experiments of (A) and (B), respectively. *P<0.05 compared to control. #P<0.05 compared to TAM alone

Discussion

Although anti-cancer actions of TAM have been originally known to be due to its ability to inhibit ER,34 TAM appears to be effective for many cancer cells in which ER is not expressed.1 Previously, we have reported that TAM induces apoptotic cell death in ER-negative HepG2 human hepatoma cells,9 which was confirmed in this study by DNA fragmentation assay through gel electrophoresis, measurement of hypodiploid DNA contents through flow cytometry and detection of cell-surface phosphatidylserine with annexin-V conjugates (Figure 1). However, the exact mechanism of this non-genomic action of TAM remains unclear.

The mechanism of the induction of apoptosis by TAM in ER-negative tumor cells is supposed to be related to non-genomic actions of TAM, for example, inhibition of calmodulin kinase35 or protein kinase C.36 In the HepG2 cells the TAM-induced apoptosis seems to be mediated by intracellular Ca2+ whose involvement in apoptosis has been extensively studied in various cell types.9,37 The results of this study suggest that ROS may also be involved in the TAM-induced apoptosis, since TAM generated ROS (Figure 2A,B), and an antioxidant NAC significantly inhibited apoptosis induced by TAM (Figure 2C).

Since interplay between intracellular Ca2+ and ROS has been shown in many cellular systems,38,39 we hypothesized that there is a cause-and-effect relationship between intracellular Ca2+ and ROS as a mediator of the TAM-induced apoptosis in the HepG2 cells. The results of the present study strongly suggest that ROS may be a downstream signal of elevated intracellular Ca2+. The TAM-induced generation of ROS was preceded by elevation of intracellular Ca2+ in a time frame (Figure 3A), and completely inhibited by reducing extracellular Ca2+ concentration with a nominal Ca2+-free medium containing EGTA and chelating intracellular Ca2+ with BAPTA/AM (Figure 3B).

The major biological process leading to oxygen-derived ROS generation is electron transport associated with mitochondrial membranes.40 In mitochondria complex III can generate ROS, especially in the presence of compounds that prolong the lifetime of ubisemiquinone.14 Therefore, if the site of the TAM-induced ROS increase is mitochondria, mitochondrial inhibitors that suppress the formation of ubisemiquinone at complex III should abolish the increase in ROS seen by treating with TAM. However, rotenone and malonate (inhibitors of NADH dehydrogenase and succinate dehydrogenase, respectively) treated alone or together, did not have a significant influence on the TAM-induced ROS generation and apoptosis (Table 1). As expected, antimycin A, a complex III inhibitor augmented the basal production of ROS probably through prolonging the lifetime of ubisemiquinone,41 but it did not enhance the ROS production and apoptosis induced by TAM (Table 1). In addition, FCCP, a mitochondrial uncoupler also increased the basal ROS level, which is consistent with the results of other studies,42 but it had no effect on the TAM-induced ROS production and apoptosis. Taken together, these results strongly suggest that mitochondria may not be the site of ROS generation induced by TAM.

ROS can also be generated by non-mitochondrial sites. ROS appear to be produced by the microsomal enzyme, cytochrome P-450, and numerous catalytic cytosolic enzymes, including cyclooxygenase, nitric oxide synthase, xanthine oxidase and ribonucleotide reductase.43 The specific inhibitors of these enzymes (500 μM metyrapone, 100 μM indomethacin, 100 μM NMMA, 100 μM allopurinol and 1.5 mM hydroxyurea, respectively) were not effective for preventing the TAM-induced ROS production and apoptosis (Table 1), demonstrating that these non-mitochondrial enzymes may not be involved in the ROS generation by TAM in the HepG2 cells.

The membrane-bound NADPH oxidase is known to produce ROS during the respiratory burst in neutrophils.44 The enzyme has also been involved in the ROS-mediated apoptosis in human leukemia cells.45 The activation of this enzyme proceeds through a multistep assembly at the plasma membrane of several components including the two subunits of cytochrome b558 (p22phox and gp91phox), the small GTP-binding proteins (Rac and Rap1A), and the cytosolic factors (p40phox, p47phox and p67phox).44,46 Recently, these components have also been detected and functionally active in non-phagocytic cells, including endothelial cells,47 vascular smooth muscle cells,48 neuroepithelial bodies of the lung49 and type I cells of the carotid body.50 Interestingly, this enzyme acts as a main system to produce ROS during oxidative stress condition in vascular cells.51,52

HepG2 cells used in this study have been shown to express these components found in the NADPH oxidase complex of neutrophils.53,54 This enzyme system appears to be a major source of ROS produced particularly in association with hypoxia-induced erythropoietin expression in the HepG2 cells.53 Therefore, we examined whether the membrane-bound NAD(P)H oxidase contributes to the TAM-induced ROS generation. The significant suppression of the TAM-induced production of ROS (Figure 4A) and apoptosis (Figure 4B) by various inhibitors of the enzyme (DPI, PAO and NEO) suggest that the membrane-bound NAD(P)H oxidase may be actively involved in the production of ROS induced by TAM.

Currently, we do not know the exact mechanism by which TAM activates the NAD(P)H oxidase in the HepG2 cells. However, antagonistic effects of Ca2+ inhibitors on the TAM-induced ROS generation (Figure 3B) suggest involvement of intracellular Ca2+ signal. Recently, Cool et al.54 have demonstrated that in HepG2 cells Rac1, a small GTP binding protein is involved in the regulation of ROS production by the non-phagocytic NAD(P)H oxidase complex. In addition, Ca2+/CaM-dependent protein kinase-II has been demonstrated to phosphorylate and regulate Tiam1,55 a Rac1-specific exchange factor.56 Thus, although speculated, there is a possibility that elevated Ca2+ by TAM activates Ca2+/CaM-dependent protein kinase-II, which in turn, activates Tiam1, leading to activation of Rac1. Moreover, Orie et al.57 have recently found that Ca2+/CaM-dependent protein kinase-II is a common signaling component in the generation of ROS in human lymphocytes. The involvement of Ca2+/CaM-dependent protein kinase-II in the TAM-induced activation of NAD(P)H oxidase in the HepG2 cells remains to be elucidated in the future.

In conclusion, TAM induced apoptosis through generation of ROS in HepG2 human hepatoblastoma cells. TAM may activate NAD(P)H oxidase via increasing intracellular Ca2+ concentration, which results in the production of ROS and apoptosis. However, since the concentration of tamoxifen used in this study (30 μM) may not be obtainable in vivo, one should consider it cautiously when these results may be interpreted as the mechanism of the actions of tamoxifen in vivo. Nevertheless, these results suggest that NAD(P)H oxidase may have a novel role in apoptotic cell death induced by TAM, an activator of intracellular Ca2+ signal in the HepG2 cells.

Materials and Methods

Materials

The powders Eagle's minimum essential medium (MEM) and Earle's basal salt solution, trypsin solution (EBSS), EGTA, TAM, NAC, rotenone, malonate, antimycin A, indomethacin, metyrapone, allopurinol, NMMA, FCCP, hydroxyurea, DPI, PAO, NEO, sodium pyruvate, probenecid, PI, ribonuclease A and all salt powders were obtained from Sigma Chemical Co. (St. Louis, MO, USA). 1-(2,5-Carboxyoxazol-2-yl-6-aminobenzfuran-5-oxyl)-2-(2′-amino-methylphenoxy)- ethane-N,N,N,N-tetraacetoxylmethyl ester (Fura-2/AM), BAPTA/AM and DCFH-DA were from Molecular Probes, Inc. (Eugene, OR, USA). Fetal bovine serum (FBS) and antibiotics (penicillin and streptomycin mixture) were purchased from GIBCO (Grand Island, NY, USA). Fura-2/AM, BAPTA/AM and DCFH-DA were prepared as stock solutions in dimethyl sulfoxide (DMSO), then diluted with aqueous medium to the final desired concentrations. The stock solutions of drugs were sterilized by filtration through 0.2 μm disc filters (Gelman Sciences: Ann Arbor, MI, USA).

Cell line and cell culture

HepG2 human hepatoblastoma cell line was purchased from American Type Culture Collection (Rockville, MA, USA). HepG2 cells were grown at 37°C in a humidified incubator under 5% CO2/95% air in a MEM supplemented with 10% FBS, 200 IU/ml penicillin, 200 μg/ml of streptomycin and 1 mM sodium pyruvate. Culture medium was replaced every other day. After attaining confluence the cells were subcultured following trypsinization.

DNA isolation and electrophoresis

DNA isolation was done according to Hockenbery et al.58 HepG2 cells were collected by centrifugation (200×g, 10 min), washed twice in phosphate buffered saline (PBS) (pH 7.4) and resuspended at a density of 4×106 cells/400 μl in hypotonic lysing buffer (5 mM Tris, 20 mM EDTA, pH 7.4) containing 0.5% Triton X-100 for 30 min at 4°C. The lysates were centrifuged at 13 000×g for 15 min at 4°C. Fragmented DNA was extracted from the supernatant with phenol-chloroform-isoamylalcohol, precipitated by addition of 2 volume of absolute ethanol and 0.1 volume of 3 mM sodium acetate, and treated with RNAse A (500 U/ml) at 37°C for 3 h. The pattern of DNA fragmentation was visualized by electrophoresis in 1.8% agarose gel containing ethidium bromide and photographed under UV light.

Intracellular ROS measurement

Relative changes in intracellular ROS in the HepG2 cells were monitored using a fluorescent probe, DCFH-DA.29 DCFH-DA diffuses through the cell membrane readily and is hydrolyzed by intracellular esterases to nonfluorescent DCFH, which is then rapidly oxidized to highly fluorescent DCF in the presence of ROS. The DCF fluorescence intensity is proportional to the amount of ROS formed intracelularly.59 Cells were washed twice and resuspended at a concentration of 4×105 cells/ml in Hank's solution. For loading DCFH-DA into the cells, cells were incubated with the dye for 2 h at a final concentration of 5 μM at 37°C. Fluorescence (excitation wavelength set at 485 nm and the emission wavelength at 530 nm) was monitored in a well-stirred cuvette.

Intracellular Ca2+ measurement

Aliquots of the HepG2 cells were washed in EBSS. Then, 5 μM Fura-2 was added, and the cells were incubated for 30 min at 37°C. Unloaded Fura-2 was removed by centrifugation at 150×g for 3 min. Cells were resuspended at a density of 2×106 cells/ml in Krebs-Ringer buffer containing 125 mM NaCl, 5 mM KCl, 1.3 mM CaCl2, 1.2 mM KH2PO4, 1.2 mM MgSO4, 5 mM NaHCO3, 25 mM HEPES, 6 mM glucose and 2.5 mM probenecid (pH 7.4). Fura-2-loaded cells were maintained at 25°C for 90 min before fluorescence measurement. For each experiment, 0.5 ml aliquot of Fura-2-loaded cells was equilibrated to 37°C in a stirred quartz cuvette. Fluorescence emission (510 nm) was monitored with the excitation wavelength cycling between 340 and 380 nm using a Hitachi F4500 fluorescence spectrophotometer. At the end of an experiment, fluorescence maximum and minimum values at each excitation wavelength were obtained by lysis of cells with 20 μg/ml digitonin (maximum) and then adding 10 mM EGTA (minimum). With the maximum and minimum values, the 340 : 380 nm fluorescence ratios were converted into free Ca2+ concentrations using a software, F-4500 Intracellular Cation Measurement System, provided by Hitachi.

Flow cytometric analysis of apoptosis

For flow cytometry analysis, HepG2 cells were collected and washed twice with PBS buffer (pH 7.4). After fixing in 80% ethanol for 30 min, cells were washed twice, and resuspended in PBS buffer (pH 7.4) containing 0.1% Triton X-100, 5 μg/ml PI and 50 μg/ml ribonuclease A for DNA staining. Cells were then analyzed by a FACScan (BIO-RAD, Hercules, CA, USA). At least 20 000 events were evaluated. All histograms were analyzed using WinBryte software (BIO-RAD, Hercules, CA, USA) to determine percentage of nuclei with hypodiploid content indicative of apoptosis.28

The normal lipid organization of the plasma membrane is altered soon after apoptosis is initiated. Thus, annexin-V binding was also employed as an indicator of apoptosis60 to demonstrate the loss of phospholipid asymmetry and the presence of phosphatidylserine on the outer layer of the plasma membrane. It was analyzed using a commercial kit (Boehringer Mannheim Biochemicals, Mannheim, Germany). Cells were washed in cold PBS, and resuspended in binding buffer. A portion of cell suspension (500 μl) was exposed to Annexin-V-FLUOS. The cells were gently vortexed, incubated at room temperature for 20 min in the dark, and then analyzed by FACScan within 1 h of staining.

Data analysis

All experiments were performed four times. Data were expressed as mean±standard error of the mean (S.E.M.) and were analyzed using one way analysis of variance (ANOVA) and Student-Newman-Keul's test for individual comparisons. P values less than 0.05 are considered statistically significant.